ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)’s share price fell 6.8% during mid-day trading on Thursday . The stock traded as low as $0.38 and last traded at $0.41. 1,631,100 shares changed hands during mid-day trading, an increase of 75% from the average session volume of 934,181 shares. The stock had previously closed at $0.44.

Separately, Maxim Group set a $4.00 price objective on ContraVir Pharmaceuticals and gave the company a “buy” rating in a research report on Monday, October 30th.

A hedge fund recently raised its stake in ContraVir Pharmaceuticals stock. Vanguard Group Inc. lifted its position in shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,414,475 shares of the biopharmaceutical company’s stock after acquiring an additional 366,192 shares during the quarter. Vanguard Group Inc. owned approximately 3.79% of ContraVir Pharmaceuticals worth $1,400,000 at the end of the most recent reporting period. 6.65% of the stock is currently owned by institutional investors and hedge funds.

WARNING: “ContraVir Pharmaceuticals (CTRV) Stock Price Down 6.8%” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at

About ContraVir Pharmaceuticals

Receive News & Stock Ratings for ContraVir Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.